SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation clinical trials

Prognostic value of early assessment by ⁶⁸Ga-DOTATATE PET/CT for the treatment of well-differentiated grade 2 gastroenteropancreatic neuroendocrine tumors with ¹⁷⁷Lutetium-oxodotreotide.”

This study looks at how well a special scan (PET/CT) can predict if a treatment called Lutetium-177 will stop certain gut and pancreas cancers from growing. It aims to see if early scan results can tell us if the treatment is working for patients with moderately growing neuroendocrine tumours.